TAKEDA PHARMACEUTICALS AMERICA, INC.

Registrant on federal lobbying filings · filed 2025 to 2026

$0 Income reported

1 Clients represented

6 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. It also reported $6,040,000 of in-house lobbying expenses, which is what a registrant files when it lobbies for itself. 1 filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the registrant's LDA id (57954), not by name.

Clients 1

TAKEDA PHARMACEUTICALS AMERICA INC $6,040,000 6 filings

Lobbyists named 1

NICHOLAS LISOWSKI 1 filing · through 2025 Congressman Bruce Westerman (Legislative Assistant) Congressman Buddy Carter (Health Policy Advisor)

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

Reported by year 2 years

2026 $2,020,000 2 filings
2025 $4,020,000 4 filings

Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 6

HOUSE OF REPRESENTATIVES 6
SENATE 6
Centers For Medicare and Medicaid Services (CMS) 4
Office of Management & Budget (OMB) 1
U.S. International Trade Commission (ITC) 1
U.S. Trade Representative (USTR) 1

Recent filings 7 total

Q2

TAKEDA PHARMACEUTICALS AMERICA INC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $610,000 expenses · posted Jul 20, 2026

View → Q1

TAKEDA PHARMACEUTICALS AMERICA INC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $1,410,000 expenses · posted Apr 20, 2026

View → Q4

TAKEDA PHARMACEUTICALS AMERICA INC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $590,000 expenses · posted Jan 20, 2026

View → Q3

TAKEDA PHARMACEUTICALS AMERICA INC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $1,370,000 expenses · posted Oct 20, 2025

View → 2A

TAKEDA PHARMACEUTICALS AMERICA INC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $1,570,000 expenses · posted Aug 26, 2025

View → Q2

TAKEDA PHARMACEUTICALS AMERICA INC Amended

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $1,520,000 expenses · posted Jul 21, 2025

View → Q1

TAKEDA PHARMACEUTICALS AMERICA INC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $490,000 expenses · posted Apr 22, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.